Profil
Saba S.
Malak served as the Chief Executive Officer & Director at CytImmune Sciences, Inc. and as a Managing Director at Putnam Investment Management LLC.
Prior to that, he worked as a Director at Advanced Practice Strategies, Inc. and as a Principal at The Boston Consulting Group, Inc. and The Boston Consulting Group Ltd. Malak holds an MBA from Harvard University, a graduate degree from the University of Pennsylvania, and an undergraduate degree from Tufts University.
Anciens postes connus de Saba S. Malak
| Sociétés | Poste | Fin |
|---|---|---|
Putnam Investment Management LLC
Putnam Investment Management LLC Investment ManagersFinance PIM is an active, long-term investment manager across the major asset classes. Their analysis of the financial markets is generally based on fundamental analysis and research, but also includes quantitative elements. PIM research is focused on developing both a top-down view of broader market performance and a bottom-up outlook for individual securities. | Analyst-Equity | 01/12/2007 |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology Develops and manufactures cytokine immunoassay kits | Directeur Général | - |
The Boston Consulting Group Ltd.
The Boston Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | - |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | - |
Advanced Practice Strategies, Inc.
Advanced Practice Strategies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides education solutions about medical risk management | Directeur/Membre du Conseil | - |
Formation de Saba S. Malak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Putnam Investment Management LLC
Putnam Investment Management LLC Investment ManagersFinance PIM is an active, long-term investment manager across the major asset classes. Their analysis of the financial markets is generally based on fundamental analysis and research, but also includes quantitative elements. PIM research is focused on developing both a top-down view of broader market performance and a bottom-up outlook for individual securities. | Finance |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology Develops and manufactures cytokine immunoassay kits | Health Technology |
Advanced Practice Strategies, Inc.
Advanced Practice Strategies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides education solutions about medical risk management | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group Ltd.
The Boston Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
















